Prognostic evaluation of resectable colorectal cancer using platelet-associated indicators
- PMID: 31289529
- PMCID: PMC6546985
- DOI: 10.3892/ol.2019.10388
Prognostic evaluation of resectable colorectal cancer using platelet-associated indicators
Abstract
Colorectal cancer (CRC) represents the third most common malignancy worldwide. The aim of the present study was to investigate the predictive values of platelet-associated indicators, including platelet count (PLT), plateletcrit (PCT), mean platelet volume (MPV) and platelet distribution width (PDW) in patients with resectable CRC. The current retrospective study included 153 patients who were pathologically diagnosed with resectable CRC. The patients were divided into two groups according to the median value of PLT, PCT, MPV or PDW. To evaluate the changes in PLT, PCT, MPV and PDW following resection and adjuvant chemotherapy, the concept of post-/pre-treatment PLT, PCT, MPV and PDW ratios was introduced, where <1 indicated decreased PLT, PCT, MPV and PDW values after treatment, and where ≥1 suggested stable or increased values. It was revealed that a low MPV prior to treatment correlated with a higher tumor stage. Surgery significantly decreased MPV, but had no impact on PLT, PCT or PDW. Adjuvant chemotherapy significantly decreased PLT and PCT, increased MPV and had no effect on PDW. After the whole course of treatment (surgery combined with adjuvant chemotherapy), PLT, PCT and PDW were significantly decreased. Kaplan-Meier plots illustrated that patients with a post-/pre-treatment MPV ratio <1 had poorer overall survival (OS), whereas the post-/pre-treatment ratios for PLT, PCT and PDW did not correlate with patient outcome. Multivariate Cox regression analysis revealed that sex, tumor size and the post-/pre-treatment MPV ratio were prognostic factors for OS. Therefore, the present results may suggest MPV as a potential prognostic factor in resectable CRC.
Keywords: colorectal cancer; overall survival; platelet; platelet-associated indicators; prognosis.
Figures





Similar articles
-
Prognostic Values of Platelet-Associated Indicators in Resectable Lung Cancers.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819837261. doi: 10.1177/1533033819837261. Technol Cancer Res Treat. 2019. PMID: 30871415 Free PMC article.
-
Association between platelet indices and the severity of the disease and mortality in patients with COVID-19.Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6731-6740. doi: 10.26355/eurrev_202111_27118. Eur Rev Med Pharmacol Sci. 2021. PMID: 34787878
-
Prognostic values of platelet-associated indicators in advanced breast cancer.Transl Cancer Res. 2019 Aug;8(4):1326-1335. doi: 10.21037/tcr.2019.07.28. Transl Cancer Res. 2019. PMID: 35116875 Free PMC article.
-
Prognostic Value of Evaluating Platelet Role, Count and Indices in Laboratory Diagnosis of Different Types of Solid Malignancies.Pak J Biol Sci. 2022 Jan;25(2):100-105. doi: 10.3923/pjbs.2022.100.105. Pak J Biol Sci. 2022. PMID: 35233997 Review.
-
Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis.BMC Gastroenterol. 2024 Jul 3;24(1):214. doi: 10.1186/s12876-024-03305-9. BMC Gastroenterol. 2024. PMID: 38961334 Free PMC article.
Cited by
-
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.Mol Cancer. 2022 Mar 25;21(1):86. doi: 10.1186/s12943-022-01556-2. Mol Cancer. 2022. PMID: 35337361 Free PMC article. Review.
-
The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions.Cancer Biomark. 2024;39(3):223-230. doi: 10.3233/CBM-230157. Cancer Biomark. 2024. PMID: 38217586 Free PMC article.
-
The Impact of Molecular Biology in the Seeding, Treatment Choices and Follow-Up of Colorectal Cancer Liver Metastases-A Narrative Review.Int J Mol Sci. 2023 Jan 6;24(2):1127. doi: 10.3390/ijms24021127. Int J Mol Sci. 2023. PMID: 36674640 Free PMC article. Review.
-
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes.Cancers (Basel). 2020 Feb 28;12(3):556. doi: 10.3390/cancers12030556. Cancers (Basel). 2020. PMID: 32121060 Free PMC article.
-
Involvement of platelet signaling pathways in colorectal cancer and new therapeutic targets.Am J Cancer Res. 2024 Nov 15;14(11):5133-5153. doi: 10.62347/PJNU8987. eCollection 2024. Am J Cancer Res. 2024. PMID: 39659922 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources